These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 10566725

  • 1. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 3. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C, Modigliani R, Rambaud JC.
    Lancet; 1996 Jan 27; 347(8996):215-9. PubMed ID: 8551879
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul 27; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 6. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 27; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 7. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
    Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Cosnes J, Lemann M, Groupe D'Etude Thérapeutique Des Affections Inflammatoires Du Tube Digestif (GETAID).
    Clin Gastroenterol Hepatol; 2009 Jan 27; 7(1):80-5. PubMed ID: 18849016
    [Abstract] [Full Text] [Related]

  • 8. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G.
    Clin Gastroenterol Hepatol; 2003 Mar 27; 1(2):122-8. PubMed ID: 15017504
    [Abstract] [Full Text] [Related]

  • 9. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis.
    Lobel EZ, Korelitz BI, Xuereb MA, Panagopoulos G.
    Am J Gastroenterol; 2004 Mar 27; 99(3):462-5. PubMed ID: 15056086
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF.
    Am J Gastroenterol; 2000 Jul 27; 95(7):1730-4. PubMed ID: 10925976
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May 27; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 May 27; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 13. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T, Korelitz BI.
    Am J Gastroenterol; 1994 Mar 27; 89(3):362-6. PubMed ID: 8122645
    [Abstract] [Full Text] [Related]

  • 14. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 15. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Michetti P, Froehlich F.
    Digestion; 2007 Apr 01; 76(2):116-29. PubMed ID: 18239403
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov 01; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

  • 17. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C, Scribano ML.
    Ital J Gastroenterol Hepatol; 1999 Nov 01; 31(6):515-8. PubMed ID: 10575572
    [Abstract] [Full Text] [Related]

  • 18. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.
    Gastroenterol Hepatol; 2000 Oct 01; 23(8):374-8. PubMed ID: 11227650
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C, Festa V, Leandro G, Moretti A, Tanga M, Koch M, Capurso L.
    Am J Gastroenterol; 2007 Apr 01; 102(4):814-9. PubMed ID: 17222316
    [Abstract] [Full Text] [Related]

  • 20. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Korelitz BI, Fuller SR, Warman JI, Goldberg MD.
    Am J Gastroenterol; 1999 Feb 01; 94(2):424-6. PubMed ID: 10022640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.